https://www.irbm.com/scientific-contributions/new-irbm-contribution-to-the-journal-of-pharmaceutical-and-biomedical-analysis/ 2019-02-05T11:55:50+00:00 https://www.irbm.com/wp-content/uploads/2017/01/dna_irbm_news.jpg https://www.irbm.com/scientific-contributions/new-irbm-contribution-to-pharmaceutics-journal/ 2019-04-19T07:54:16+00:00 https://www.irbm.com/wp-content/uploads/irbm_scientific_contributions_magic_bullet_project-1.jpg https://www.irbm.com/scientific-contributions/new-irbm-contribution-to-acs-medicinal-chemistry-letters/ 2019-05-09T13:25:03+00:00 https://www.irbm.com/wp-content/uploads/iStock-909908830.jpg https://www.irbm.com/news/irbm-chemistry-today-contribution/ 2019-05-28T14:38:27+00:00 https://www.irbm.com/wp-content/uploads/MG_2840.jpg https://www.irbm.com/news/tryptophan-news/ 2019-06-05T23:34:02+00:00 https://www.irbm.com/wp-content/uploads/iStock-855981136-1.jpg https://www.irbm.com/news/first-targeted-protein-degrader-begins-phase-i-clinical-trial/ 2019-06-05T23:35:47+00:00 https://www.irbm.com/wp-content/uploads/irbm-news-1.jpg https://www.irbm.com/scientific-contributions/eatris-collaboration/ 2019-06-10T15:21:35+00:00 https://www.irbm.com/wp-content/uploads/IRBM.001.jpeg https://www.irbm.com/scientific-contributions/new-irbm-contribution-to-the-journal-of-clinical-investigation/ 2019-06-14T15:27:11+00:00 https://www.irbm.com/wp-content/uploads/iStock-537625666.jpg https://www.irbm.com/scientific-contributions/irbm-contribution-to-molecular-pharmaceutics/ 2019-06-20T15:30:18+00:00 https://www.irbm.com/wp-content/uploads/Molecular-Pharmaceutics-image.jpg https://www.irbm.com/scientific-contributions/irbm-contribution-to-medicinal-chemistry-letters-by-the-american-chemical-society/ 2019-06-27T16:14:19+00:00 https://www.irbm.com/wp-content/uploads/brain.jpg https://www.irbm.com/scientific-contributions/new-irbm-contribution-to-metabolites/ 2019-07-26T08:56:50+00:00 https://www.irbm.com/wp-content/uploads/iStock-1147577976.jpg https://www.irbm.com/scientific-contributions/irbm-contribution-to-frontiers-in-neuroscience/ 2019-08-30T11:27:45+00:00 https://www.irbm.com/wp-content/uploads/image-2.png https://www.irbm.com/news/new-irbm-contribution-to-the-medicine-maker/ 2019-10-10T09:21:52+00:00 https://www.irbm.com/wp-content/uploads/Screenshot-2019-10-10-at-10.19.33.png https://www.irbm.com/press-releases/irbm-signs-agreement-with-md-anderson-cancer-center-to-generate-novel-immune-checkpoint-monoclonal-antibodies/ 2019-11-21T17:25:38+00:00 https://www.irbm.com/wp-content/uploads/IRBM.png https://www.irbm.com/press-releases/chdi-foundation-extends-collaboration-with-irbm-to-accelerate-development-of-huntingtons-disease-therapeutics/ 2019-11-21T17:26:02+00:00 https://www.irbm.com/wp-content/uploads/2017/01/dna_irbm_news.jpg https://www.irbm.com/news/new-irbm-contribution-to-bioanalysis-zone/ 2019-11-26T10:47:39+00:00 https://www.irbm.com/wp-content/uploads/iStock-1082350496.jpg https://www.irbm.com/news/the-jenner-institute-signs-an-agreement-with-advent-to-develop-a-novel-coronavirus-vaccine/ 2020-02-07T14:15:14+00:00 https://www.irbm.com/wp-content/uploads/coronavirus.jpg https://www.irbm.com/videos/irbm-the-factory-of-the-vaccine-la7-tagada-25th-february/ 2020-04-28T12:43:46+00:00 https://www.irbm.com/videos/irbm-working-tirelessly-to-produce-a-vaccine-rete-4-stasera-italia-6th-march/ 2020-04-28T12:46:37+00:00 https://www.irbm.com/videos/irbm-is-close-to-a-vaccine-tg-com-24-13th-march/ 2020-04-28T12:50:38+00:00 https://www.irbm.com/videos/piero-di-lorenzo-irbm-fights-the-coronavirus-in-its-labs-la7-di-martedi-17th-march/ 2020-04-28T13:01:40+00:00 https://www.irbm.com/videos/good-news-from-irbm-rai-tgr-lazio-18th-marc/ 2020-04-28T13:03:59+00:00 https://www.irbm.com/videos/piero-di-lorenzo-irbm-produced-the-first-batch-of-vaccines-la7-coffee-break-17th-march/ 2020-04-28T13:14:10+00:00 https://www.irbm.com/videos/piero-di-lorenzo-kicks-offthe-vaccine-manufacturing-against-covid-19-sky-tg-24-15th-march/ 2020-04-28T13:14:30+00:00 https://www.irbm.com/scientific-contributions/irbms-chief-science-officer-carlo-toniatti-is-featured-in-the-medicine-makers-power-list/ 2020-04-28T13:16:16+00:00 https://www.irbm.com/wp-content/uploads/medicine-maker-carlo-toniatti-irbm2.jpg https://www.irbm.com/videos/piero-di-lorenzo-the-road-map-to-get-a-vaccine-la7-coffee-break-25th-february/ 2020-04-28T14:25:19+00:00 https://www.irbm.com/videos/worldwide-race-for-a-vaccine-against-coronavirus-irbm-on-the-frontline-rai-2-petrolio-24th-february/ 2020-05-14T18:42:44+00:00 https://www.irbm.com/videos/covid-19-how-a-vaccine-is-produced-irbm-fights-against-coronavirus-rai-1-unomattina-14-02-2020/ 2020-05-14T18:43:02+00:00 https://www.irbm.com/videos/coronavirus-a-worse-threat-than-terrorism-rete-4-dritto-rovescio-12th-february-2020/ 2020-05-14T18:43:15+00:00 https://www.irbm.com/videos/tg1-news-interview-pietro-di-lorenzo-stefania-di-marco-rai1-tg1-12th-february-2020/ 2020-05-14T18:43:38+00:00 https://www.irbm.com/videos/coronavirus-matteo-liguori-irbm-managing-director-we-are-working-to-manufacture-a-vaccine-agenzia-dire/ 2020-05-14T18:54:15+00:00 https://www.irbm.com/videos/the-hunt-for-the-vaccine-to-stop-covid-19rete-4-quarto-grado-27th-march/ 2020-05-14T18:58:11+00:00 https://www.irbm.com/videos/coronaviurs-stefania-di-marco-explains-the-steps-of-vaccine-production-agenzia-dire/ 2020-05-14T18:58:48+00:00 https://www.irbm.com/videos/the-first-anti-coronavirus-vaccine-produced-in-italyrete-4-stasera-italia-29th-march/ 2020-05-14T19:00:44+00:00 https://www.irbm.com/videos/the-serarch-for-a-vaccine-runs-fast-canale-5-tg5-14th-april/ 2020-05-14T19:46:06+00:00 https://www.irbm.com/videos/agora-interview-with-piero-di-lorenzo-rai-3-agora-14th-april/ 2020-05-14T19:47:32+00:00 https://www.irbm.com/news/irbm-supporting-the-effort-to-cope-with-the-impact-of-coronavirus/ 2020-05-20T15:18:00+00:00 https://www.irbm.com/wp-content/uploads/blood-donation-irbm-emaroma1.jpg https://www.irbm.com/news/in-memory-of-maurizio-botta-his-vision-of-medicinal-chemistry/ 2020-05-21T15:39:12+00:00 https://www.irbm.com/wp-content/uploads/irbm_in-memory-of-maurizio-botta2.jpg https://www.irbm.com/videos/firts-batch-for-human-trials-rete-4-stasera-italia-14th-april/ 2020-06-25T16:02:17+00:00 https://www.irbm.com/videos/sky-tg24-interview-with-matteo-liguori-sky-sky-tg24-14th-april/ 2020-06-25T16:02:22+00:00 https://www.irbm.com/videos/laria-che-tira-interview-with-carlo-toniatti-la7-laria-che-tira-15th-april/ 2020-06-25T16:02:26+00:00 https://www.irbm.com/videos/a-race-against-time-tgcom24-12th-april/ 2020-06-25T16:10:15+00:00 https://www.irbm.com/videos/human-trials-will-begin-soon-canale-5-tg5-13th-april/ 2020-06-25T16:11:28+00:00 https://www.irbm.com/videos/porta-a-porta-interview-with-piero-di-lorenzo-rai-1-14th-april/ 2020-06-25T16:12:14+00:00 https://www.irbm.com/videos/coffee-break-interview-with-piero-di-lorenzo-la7-15th-april/ 2020-06-25T16:13:50+00:00 https://www.irbm.com/videos/tg-1-interview-with-piero-di-lorenzo-tg-1-15th-april/ 2020-06-25T16:14:38+00:00 https://www.irbm.com/press-releases/irbm-to-collaborate-with-msd-to-develop-peptides-against-coronavirus/ 2020-07-21T11:08:53+00:00 https://www.irbm.com/wp-content/uploads/IRBM-to-collaborate-with-MSD.jpg https://www.irbm.com/web-review/positive-results-from-initial-clinical-trials-of-covid-19-vaccine-azd1222-manufactured-by-irbms-advent/ 2020-07-21T13:00:49+00:00 https://www.irbm.com/wp-content/uploads/IRBM-advent-covid-19-vaccine-AZD1222.jpg https://www.irbm.com/videos/la-vita-in-diretta-interview-with-piero-di-lorenzo-rai-1-17th-april/ 2020-07-23T15:53:08+00:00 https://www.irbm.com/press-review/interview-with-irbms-dr-maria-veneziano-on-pharmacokinetic-studies/ 2020-09-17T07:23:36+00:00 https://www.irbm.com/wp-content/uploads/irbm-maria-veneziano.jpg https://www.irbm.com/videos/rai-3-tgr-lonardo-21st-april/ 2020-11-09T16:45:28+00:00 https://www.irbm.com/videos/canale-5-non-e-la-durso-live-19th-april/ 2020-11-09T16:46:29+00:00 https://www.irbm.com/videos/sky-tg24-interview-with-pietro-di-lorenzo-sky-sky-tg24-24th-april/ 2020-11-09T16:47:44+00:00 https://www.irbm.com/videos/rai-3-buongiorno-regione-lazio-28th-april/ 2020-11-09T16:48:40+00:00 https://www.irbm.com/videos/rai-2-patriae-5th-may/ 2020-11-09T16:49:30+00:00 https://www.irbm.com/press-review/irbm-cso-carlo-toniatti-on-the-evolving-cro-role-in-drug-development-emerging-approaches-in-oncology-the-potential-of-ai/ 2021-10-19T15:24:04+00:00 https://www.irbm.com/wp-content/uploads/irbm-Carlo-Toniatti-drug-development-trends1.jpg https://www.irbm.com/wp-content/uploads/Pharma-Boardroom-logo.png https://www.irbm.com/press-review/the-power-of-nmr-in-drug-discovery/ 2021-12-17T13:24:09+00:00 https://www.irbm.com/wp-content/uploads/The-Power-of-NMR-in-Drug-Discovery.jpg https://www.irbm.com/scientific-contributions/irbm-contribution-to-medicinal-chemistry-letters-by-the-american-chemical-society-2/ 2022-01-25T11:24:41+00:00 https://www.irbm.com/wp-content/uploads/HIV.jpg https://www.irbm.com/scientific-contributions/irbm-contribution-to-the-journal-of-pharmaceutical-and-biomedical-analysis/ 2022-01-25T11:26:28+00:00 https://www.irbm.com/wp-content/uploads/iStock-544581662.jpg https://www.irbm.com/scientific-publications/publications-2008/2-trifluoroacetylthiophene-oxadiazoles-as-potent-and-selective-class-ii-human-histone-deacetylase-inhibitors/ 2022-02-18T16:53:36+00:00 https://www.irbm.com/scientific-publications/publications-2008/high-throughput-microsomal-stability-assay-for-screening-new-chemical-entities-in-drug-discovery/ 2022-02-18T16:53:44+00:00 https://www.irbm.com/scientific-publications/publications-2009/a-therapeutic-cancer-vaccine-targeting-carcinoembryonic-antigen-in-intestinal-carcinomas/ 2022-02-22T10:16:14+00:00 https://www.irbm.com/scientific-publications/publications-2009/studies-of-the-metabolic-stability-in-cells-of-5-trifluoroacetylthiophene-2-carboxamides-and-identification-of-more-stable-class-ii-histone-deacetylase-hdac-inhibitors/ 2022-02-22T10:16:28+00:00 https://www.irbm.com/scientific-publications/publications-2009/an-oral-tlr7-agonist-is-a-potent-adjuvant-of-dna-vaccination-in-transgenic-mouse-tumor-models/ 2022-02-22T10:16:41+00:00 https://www.irbm.com/scientific-publications/publications-2009/discovery-of-pentacyclic-compounds-as-potent-inhibitors-of-hepatitis-c-virus-ns5b-rna-polymerase/ 2022-02-22T10:16:54+00:00 https://www.irbm.com/scientific-publications/publications-2009/a-novel-chimpanzee-serotype-based-adenoviral-vector-as-delivery-tool-for-cancer-vaccines/ 2022-02-22T10:17:03+00:00 https://www.irbm.com/scientific-publications/publications-2009/synthesis-and-evaluation-of-novel-phosphoramidate-prodrugs-of-2%e2%80%b2-methyl-cytidine-as-inhibitors-of-hepatitis-c-virus-ns5b-polymerase/ 2022-02-22T10:17:14+00:00 https://www.irbm.com/scientific-publications/publications-2009/3-hydroxy-4-oxo-4h-pyrido12-apyrimidine-2-carboxylates-a-new-class-of-hiv-1-integrase-inhibitors/ 2022-02-22T10:17:25+00:00 https://www.irbm.com/scientific-publications/publications-2009/inhibitors-of-hepatitis-c-virus-ns3-4a-alpha-ketoamide-based-macrocyclic-inhibitors/ 2022-02-22T10:17:35+00:00 https://www.irbm.com/scientific-publications/publications-2009/comparative-expression-pathway-analysis-of-human-and-canine-mammary-tumors/ 2022-02-22T10:17:45+00:00 https://www.irbm.com/scientific-publications/publications-2009/phosphorous-acid-analogs-of-novel-p2-p4-macrocycles-as-inhibitors-of-hcv-ns3-protease/ 2022-02-22T10:17:53+00:00 https://www.irbm.com/scientific-publications/publications-2009/synthetic-peptide-vaccines-the-quest-to-develop-peptide-vaccines-for-influenza-hiv-and-alzheimers-disease/ 2022-02-22T10:18:03+00:00 https://www.irbm.com/scientific-publications/publications-2009/a-strategy-for-selectively-shielding-portions-of-a-peptide-protein-from-immune-response-while-maintaining-immunogenicity-of-contiguous-epitopes/ 2022-02-22T10:18:12+00:00 https://www.irbm.com/scientific-publications/publications-2009/a-peptide-vaccine-based-on-retro-inverso-beta-amyloid-sequences-fails-to-elicit-a-cross-reactive-immune-response/ 2022-02-22T10:19:16+00:00 https://www.irbm.com/scientific-publications/publications-2009/smoothened-antagonists-a-promising-new-class-of-antitumor-agents/ 2022-02-22T10:19:25+00:00 https://www.irbm.com/scientific-publications/publications-2009/discovery-of-a-potent-class-i-selective-ketone-histone-deacetylase-inhibitor-with-antitumor-activity-in-vivo-and-optimized-pharmacokinetic-properties/ 2022-02-22T10:19:52+00:00 https://www.irbm.com/scientific-publications/publications-2009/cyclic-phosphoramidates-as-prodrugs-of-2%e2%80%b2-c-methylcytidine/ 2022-02-22T10:20:06+00:00 https://www.irbm.com/scientific-publications/publications-2009/an-indirect-method-to-measure-trimerization-constants-using-surface-plasmon-resonance/ 2022-02-22T10:20:15+00:00 https://www.irbm.com/scientific-publications/publications-2009/n-4-fluorobenzyl-3-hydroxy-99-dimethyl-4-oxo-6789-tetrahydro-4h-pyrazino12-apyrimidine-2-carboxamides-a-novel-class-of-potent-hiv-1-integrase-inhibitors/ 2022-02-22T10:20:24+00:00 https://www.irbm.com/scientific-publications/publications-2009/discovery-of-n-1-aryl-1h-indazol-5-ylmethylamides-derivatives-as-smoothened-antagonists-for-inhibition-of-the-hedgehog-pathway/ 2022-02-22T10:20:36+00:00 https://www.irbm.com/scientific-publications/publications-2009/identification-of-substituted-pyrazolo15-aquinazolin-54h-one-as-potent-polyadp-ribosepolymerase-1-parp-1-inhibitors/ 2022-02-22T10:20:43+00:00 https://www.irbm.com/scientific-publications/publications-2009/identification-of-aminoethyl-pyrrolo-dihydroisoquinolinones-as-novel-polyadp-ribose-polymerase-1-inhibitors/ 2022-02-22T10:20:51+00:00 https://www.irbm.com/scientific-publications/publications-2009/metabolism-related-liabilities-of-a-potent-histone-deacetylase-hdac-inhibitor-and-relevance-of-the-route-of-administration-on-its-metabolic-fate/ 2022-02-22T10:20:59+00:00 https://www.irbm.com/scientific-publications/publications-2009/dihydroxy-pyrimidine-and-n-methylpyrimidone-hiv-integrase-inhibitors-improving-cell-based-activity-by-the-quaternarization-of-a-chiral-center/ 2022-02-22T10:21:07+00:00 https://www.irbm.com/scientific-publications/publications-2009/loss-of-histone-deacetylase-4-causes-segregation-defects-during-mitosis-of-p53-deficient-human-tumor-cells/ 2022-02-22T10:21:15+00:00 https://www.irbm.com/scientific-publications/publications-2009/coadministration-of-telomerase-genetic-vaccine-and-a-novel-tlr9-agonist-in-nonhuman-primates/ 2022-02-22T10:21:23+00:00 https://www.irbm.com/scientific-publications/publications-2009/inhibitors-of-the-hepatitis-c-virus-ns3-protease-with-basic-amine-functionality-at-the-p3-amino-acid-n-terminus-discovery-and-optimization-of-a-new-series-of-p2-p4-macrocycles/ 2022-02-22T10:21:31+00:00 https://www.irbm.com/scientific-publications/publications-2009/mass-spectrometry-study-of-prl-3-phosphatase-inactivation-by-disulfide-bond-formation-and-cysteine-into-glycine-conversion/ 2022-02-22T10:21:40+00:00 https://www.irbm.com/scientific-publications/publications-2009/2-d-difference-in-gel-electrophoresis-combined-with-pro-q-diamond-staining-a-successful-approach-for-the-identification-of-kinase-phosphatase-targets/ 2022-02-22T10:21:51+00:00 https://www.irbm.com/scientific-publications/publications-2009/engineered-adenovirus-serotypes-for-overcoming-anti-vector-immunity/ 2022-02-22T10:22:00+00:00 https://www.irbm.com/scientific-publications/publications-2009/phosphoramidate-prodrugs-of-2%e2%80%b2-c-methylcytidine-for-therapy-of-hepatitis-c-virus-infection/ 2022-02-22T10:22:07+00:00 https://www.irbm.com/scientific-publications/publications-2009/2-3-thienyl-56-dihydroxypyrimidine-4-carboxylic-acids-as-inhibitors-of-hcv-ns5b-rdrp/ 2022-02-22T10:22:17+00:00 https://www.irbm.com/wp-content/uploads/133-HCV-NS5B-RdRp.png https://www.irbm.com/scientific-publications/publications-2009/discovery-of-2-4-3s-piperidin-3-ylphenyl-2h-indazole-7-carboxamide-mk-4827-a-novel-oral-polyadp-ribosepolymerase-parp-inhibitor-efficacious-in-brca-1-and-2-mutant-tumors/ 2022-02-22T10:22:26+00:00 https://www.irbm.com/scientific-publications/publications-2009/identification-and-biological-evaluation-of-a-series-of-1h-benzodeisoquinoline-132h-diones-as-hepatitis-c-virus-ns5b-polymerase-inhibitors/ 2022-02-22T10:22:34+00:00 https://www.irbm.com/scientific-publications/publications-2009/identification-of-novel-selective-and-stable-inhibitors-of-class-ii-histone-deacetylases-validation-studies-of-the-inhibition-of-the-enzymatic-activity-of-hdac4-by-small-molecules-as-a-novel-approa/ 2022-02-22T10:22:44+00:00 https://www.irbm.com/scientific-publications/publications-2010/turbulent-flow-chromatography-tfc-tandem-mass-spectrometry-supporting-in-vitro-vivo-studies-of-nces-in-high-throughput-fashion/ 2022-02-22T10:26:25+00:00 https://www.irbm.com/scientific-publications/publications-2010/novel-potent-apoa-i-peptide-mimetics-that-stimulate-cholesterol-efflux-and-pre-%ce%b2-particle-formation-in-vitro/ 2022-02-22T10:26:31+00:00 https://www.irbm.com/scientific-publications/publications-2010/novel-p2-p4-macrocyclic-inhibitors-of-hcv-ns3-4a-protease-by-p3-succinamide-fragment-depeptidization-strategy/ 2022-02-22T10:26:37+00:00 https://www.irbm.com/scientific-publications/publications-2010/telomerase-and-her-2-neu-as-targets-of-genetic-cancer-vaccines-in-dogs/ 2022-02-22T10:26:44+00:00 https://www.irbm.com/scientific-publications/publications-2010/synthesis-and-biological-evaluation-of-substituted-2-phenyl-2h-indazole-7-carboxamides-as-potent-polyadp-ribose-polymerase-parp-inhibitors/ 2022-02-22T10:26:53+00:00 https://www.irbm.com/wp-content/uploads/128-synthesis-polymerase-inhibitors.png https://www.irbm.com/scientific-publications/publications-2010/discovery-and-sar-of-novel-potent-and-selective-hexahydrobenzonaphthyridinone-inhibitors-of-polyadp-ribosepolymerase-1-parp-1/ 2022-02-22T10:26:59+00:00 https://www.irbm.com/scientific-publications/publications-2010/development-of-substituted-6-4-fluoro-3-piperazin-1-ylcarbonylbenzyl-45-dimethylpyridazin-32h-ones-as-potent-polyadp-ribose-polymerase-1-parp-1-inhibitors-active-in-brca-deficient-cells/ 2022-02-22T10:27:07+00:00 https://www.irbm.com/scientific-publications/publications-2010/identification-and-sar-of-novel-pyrrolo12-apyrazin-12h-one-derivatives-as-inhibitors-of-polyadp-ribose-polymerase-1-parp-1/ 2022-02-22T10:27:23+00:00 https://www.irbm.com/scientific-publications/publications-2010/enhancement-of-intestinal-absorption-of-2-methyl-cytidine-prodrugs/ 2022-02-22T10:27:33+00:00 https://www.irbm.com/scientific-publications/publications-2010/allosteric-inhibitors-of-hepatitis-c-virus-ns5b-polymerase-thumb-domain-site-ii-structure-based-design-and-synthesis-of-new-templates/ 2022-02-22T10:27:46+00:00 https://www.irbm.com/scientific-publications/publications-2010/immunological-markers-of-cancer-vaccine-efficacy-and-their-clinical-relevance/ 2022-02-22T10:27:55+00:00 https://www.irbm.com/scientific-publications/publications-2010/development-of-2-pyrrolidinyl-n-methyl-pyrimidones-as-potent-and-orally-bioavailable-hiv-integrase-inhibitors/ 2022-02-22T10:28:19+00:00 https://www.irbm.com/scientific-publications/publications-2010/the-metabolism-and-disposition-of-a-potent-inhibitor-of-hepatitis-c-virus-ns3-4a-protease/ 2022-02-22T10:28:25+00:00 https://www.irbm.com/scientific-publications/publications-2010/coadministration-of-telomerase-genetic-vaccine-and-a-novel-tlr9-agonist-in-nonhuman-primates-erratum-to-document-cited-in-ca151356283/ 2022-02-22T10:28:31+00:00 https://www.irbm.com/scientific-publications/publications-2010/growth-delay-of-human-bladder-cancer-cells-by-prostate-stem-cell-antigen-downregulation-is-associated-with-activation-of-immune-signaling-pathways/ 2022-02-22T10:28:38+00:00 https://www.irbm.com/scientific-publications/publications-2010/kinase-bypass-approach-for-the-treatment-of-hepatitis-c-virus-infection/ 2022-02-22T10:28:47+00:00 https://www.irbm.com/scientific-publications/publications-2010/regioselective-synthesis-of-78-dihydropyrrolo12-apyrimidin-46h-ones-and-78-dihydropyrrolo12-apyrimidin-26h-ones/ 2022-02-22T10:28:53+00:00 https://www.irbm.com/wp-content/uploads/127-regioselective-synthesis.png https://www.irbm.com/scientific-publications/publications-2010/advances-in-the-development-of-macrocyclic-inhibitors-of-hepatitis-c-virus-ns3-4a-protease-3/ 2022-02-22T10:29:00+00:00 https://www.irbm.com/scientific-publications/publications-2010/the-discovery-of-isentress-the-first-in-class-hiv-integrase-inhibitor-from-hit-to-drug-2/ 2022-02-22T10:29:07+00:00 https://www.irbm.com/scientific-publications/publications-2011/intratumor-rna-interference-of-cell-cycle-genes-slows-down-tumor-progression/ 2022-02-22T10:29:49+00:00 https://www.irbm.com/scientific-publications/publications-2011/identification-of-mk-5710-8as-8a-methyl-13-dioxo-2-1s2r-2-phenylcyclo-propyl-n-1-phenyl-1h-pyrazol-5-ylhexahydro-imidazo15-apyrazine-71h-carboxamide-a-potent-smoothened-antagonist-f/ 2022-02-22T10:30:00+00:00 https://www.irbm.com/scientific-publications/publications-2011/identification-of-mk-5710-8as-8a-methyl-13-dioxo-2-1s2r-2-phenylcyclopropyl-n-1-phenyl-1h-pyrazol-5-ylhexahydroimid-azo15-apyrazine-71h-carboxamide-a-potent-smoothened-antagonist-for/ 2022-02-22T10:30:06+00:00 https://www.irbm.com/scientific-publications/publications-2011/n-2-alkylaminoethyl-4-124-oxadiazol-5-ylpiperazine-1-carboxamides-as-highly-potent-smoothened-antagonists/ 2022-02-22T10:30:14+00:00 https://www.irbm.com/scientific-publications/publications-2011/identification-of-a-series-of-4-3-quinolin-2-yl-124-oxadiazol-5-ylpiperazinyl-ureas-as-potent-smoothened-antagonist-hedgehog-pathway-inhibitors/ 2022-02-22T10:30:21+00:00 https://www.irbm.com/scientific-publications/publications-2011/structure-of-herpes-simplex-virus-glycoprotein-d-bound-to-the-human-receptor-nectin-1/ 2022-02-22T10:30:28+00:00 https://www.irbm.com/scientific-publications/publications-2011/mechanistic-implications-for-ldl-receptor-degradation-from-the-pcsk9-ldlr-structure-at-neutral-ph/ 2022-02-22T10:30:36+00:00 https://www.irbm.com/scientific-publications/publications-2011/development-of-a-scalable-chiral-synthesis-of-mk-3281-an-inhibitor-of-the-hepatitis-c-virus-ns5b-polymerase/ 2022-02-22T10:30:43+00:00 https://www.irbm.com/wp-content/uploads/105-hepatitis-c-virus.png https://www.irbm.com/scientific-publications/publications-2012/discovery-of-mk-5172-a-macrocyclic-hepatitis-c-virus-ns3-4a-protease-inhibitor/ 2022-02-22T10:36:34+00:00 https://www.irbm.com/wp-content/uploads/103-MK-5172.png https://www.irbm.com/scientific-publications/publications-2012/pegylation-of-neuromedin-u-yields-a-promising-candidate-for-the-treatment-of-obesity-and-diabetes/ 2022-02-22T10:36:44+00:00 https://www.irbm.com/scientific-publications/publications-2013/further-molecular-characterisation-of-the-ovt73-transgenic-sheep-model-of-huntingtons-disease-identifies-cortical-aggregates/ 2022-02-22T10:41:55+00:00 https://www.irbm.com/scientific-publications/publications-2013/a-transgenic-minipig-model-of-huntingtons-disease/ 2022-02-22T10:42:02+00:00 https://www.irbm.com/scientific-publications/publications-2013/a-pegylated-analog-of-the-gut-hormone-oxyntomodulin-with-long-lasting-antihyperglycemic-insulinotropic-and-anorexigenic-activity/ 2022-02-22T10:42:12+00:00 https://www.irbm.com/scientific-publications/publications-2014/immunogenicity-and-therapeutic-efficacy-of-a-dual-component-genetic-cancer-vaccine-cotargeting-carcinoembryonic-antigen-and-her2-neu-in-preclinical-models/ 2022-02-22T10:51:08+00:00 https://www.irbm.com/scientific-publications/publications-2014/development-of-a-neuromedin-u-human-serum-albumin-conjugate-as-a-long-acting-candidate-for-the-treatment-of-obesity-and-diabetes-comparison-with-the-pegylated-peptide/ 2022-02-22T10:51:15+00:00 https://www.irbm.com/scientific-publications/publications-2014/niraparib-mk-4827-a-novel-polyadp-ribose-polymerase-inhibitor-radiosensitizes-human-lung-and-breast-cancer-cells/ 2022-02-22T10:51:22+00:00 https://www.irbm.com/scientific-publications/publications-2015/peptide-nucleic-acids-targeting-s-globin-mrnas-selectively-inhibit-hemoglobin-production-in-murine-erythroleukemia-cells/ 2022-02-22T11:02:59+00:00 https://www.irbm.com/scientific-publications/publications-2015/development-and-validation-of-a-luminescence-based-medium-throughput-assay-for-drug-screening-in-schistosoma-mansoni/ 2022-02-22T11:03:13+00:00 https://www.irbm.com/scientific-publications/publications-2015/a-single-run-liquid-chromatography-mass-spectrometry-method-to-quantify-neuroactive-kynurenine-pathway-metabolites-in-rat-plasma/ 2022-02-22T11:03:19+00:00 https://www.irbm.com/scientific-publications/publications-2015/a-chemogenomic-screening-identifies-ck2-as-a-target-for-pro-senescence-therapy-in-pten-deficient-tumours/ 2022-02-22T11:03:27+00:00 https://www.irbm.com/scientific-publications/publications-2015/detection-of-huntingtin-exon-1-phosphorylation-by-phos-tag-sds-page-predominant-phosphorylation-on-threonine-3-and-regulation-by-ikks/ 2022-02-22T11:03:33+00:00 https://www.irbm.com/scientific-publications/publications-2015/high-affinity-binders-to-epha2-isolated-from-abdurin-scaffold-libraries-characterization-binding-and-tumor-targeting/ 2022-02-22T11:03:39+00:00 https://www.irbm.com/scientific-publications/publications-2014/polyglutamine-and-temperature-dependent-conformational-rigidity-in-mutant-huntingtin-revealed-by-immunoassays-and-circular-dichroism-spectroscopy/ 2022-02-22T11:16:23+00:00 https://www.irbm.com/scientific-publications/publications-2015/polyglutamine-and-temperature-dependent-conformational-rigidity-in-mutant-huntingtin-revealed-by-immunoassays-and-circular-dichroism-spectroscopy-2/ 2022-02-22T11:24:29+00:00 https://www.irbm.com/scientific-publications/publications-2016/use-of-dilute-and-shoot-liquid-chromatography-high-resolution-mass-spectrometry-in-preclinical-research-application-to-a-dmpk-study-of-perhexiline-in-mouse-plasma/ 2022-02-22T11:40:15+00:00 https://www.irbm.com/scientific-publications/publications-2016/discovery-of-a-selective-series-of-inhibitors-of-plasmodium-falciparum-hdacs/ 2022-02-22T11:40:27+00:00 https://www.irbm.com/wp-content/uploads/81-inhibitors-plasmodium-falciparum.png https://www.irbm.com/scientific-publications/publications-2016/crosstalk-between-mismatch-repair-and-base-excision-repair-in-human-gastric-cancer/ 2022-02-22T11:40:38+00:00 https://www.irbm.com/scientific-publications/publications-2016/discovery-and-characterization-of-novel-anti-schistosomal-properties-of-the-anti-anginal-drug-perhexiline-and-its-impact-on-schistosoma-mansoni-male-and-female-reproductive-systems/ 2022-02-22T11:40:41+00:00 https://www.irbm.com/scientific-publications/publications-2016/vitamin-b12-ameliorates-the-phenotype-of-a-mouse-model-of-digeorge-syndrome/ 2022-02-22T11:40:55+00:00 https://www.irbm.com/scientific-publications/publications-2017/an-efficient-liquid-chromatography-high-resolution-mass-spectrometry-approach-for-the-optimization-of-the-metabolic-stability-of-therapeutic-peptides/ 2022-02-22T13:31:07+00:00 https://www.irbm.com/scientific-publications/publications-2017/mitotic-cell-death-induction-by-targeting-the-mitotic-spindle-with-tubulin-inhibitory-indole-derivative-molecules/ 2022-02-22T13:31:16+00:00 https://www.irbm.com/scientific-publications/publications-2017/understanding-the-molecular-determinant-of-reversible-human-monoamine-oxidase-b-inhibitors-containing-2h-chromen-2-one-core-structure-based-and-ligand-based-derived-three-dimensional-quantitative-str/ 2022-02-22T13:31:33+00:00 https://www.irbm.com/scientific-publications/publications-2017/identification-by-high-throughput-screening-of-pseudomonas-acyl-coenzyme-a-synthetase-inhibitors/ 2022-02-22T13:31:42+00:00 https://www.irbm.com/scientific-publications/publications-2017/pink1-and-becn1-relocalize-at-mitochondria-associated-membranes-during-mitophagy-and-promote-er-mitochondria-tethering-and-autophagosome-formation/ 2022-02-22T13:31:52+00:00 https://www.irbm.com/scientific-publications/publications-2017/high-affinity-click-rgd-peptidomimetics-as-radiolabeled-probes-for-imaging-av-s3-integrin/ 2022-02-22T13:32:02+00:00 https://www.irbm.com/scientific-publications/publications-2017/polyglutamine-expansion-affects-huntingtin-conformation-in-multiple-huntingtons-disease-models/ 2022-02-22T13:32:12+00:00 https://www.irbm.com/scientific-publications/publications-2017/nuclear-factor-erythroid-derived-2-like-2-nrf2-drug-discovery-biochemical-toolbox-to-develop-nrf2-activators-by-reversible-binding-of-kelch-like-ech-associated-protein-1-keap1/ 2022-02-22T13:32:27+00:00 https://www.irbm.com/scientific-publications/publications-2017/discovery-by-organism-based-high-throughput-screening-of-new-multi-stage-compounds-affecting-schistosoma-mansoni-viability-egg-formation-and-production/ 2022-02-22T13:32:37+00:00 https://www.irbm.com/scientific-publications/publications-2017/vitamin-b12-ameliorates-the-phenotype-of-a-mouse-model-of-digeorge-syndrome-2/ 2022-02-22T13:32:44+00:00 https://www.irbm.com/scientific-publications/publications-2017/insights-on-the-conformational-dynamics-of-human-frataxin-through-modifications-of-loop-1/ 2022-02-22T13:32:50+00:00 https://www.irbm.com/scientific-publications/publications-2017/largazole-analogues-as-histone-deacetylase-inhibitors-and-anticancer-agents-an-overview-of-structure-activity-relationships/ 2022-02-22T13:32:59+00:00 https://www.irbm.com/scientific-publications/publications-2017/validation-of-ultrasensitive-mutant-huntingtin-detection-in-human-cerebrospinal-fluid-by-single-molecule-counting-immunoassay/ 2022-02-22T13:33:05+00:00 https://www.irbm.com/scientific-publications/publications-2017/structure-based-identification-of-hiv-1-nucleocapsid-protein-inhibitors-active-against-wild-type-and-drug-resistant-hiv-1-strains/ 2022-02-22T13:33:20+00:00 https://www.irbm.com/scientific-publications/publications-2017/designing-an-effective-peptide-vaccine/ 2022-02-22T13:33:25+00:00 https://www.irbm.com/scientific-publications/publications-2017/crosstalk-between-mismatch-repair-and-base-excision-repair-in-human-gastric-cancer-2/ 2022-02-22T13:33:34+00:00 https://www.irbm.com/scientific-publications/publications-2018/structure-based-identification-of-hiv-1-nucleocapsid-protein-inhibitors-active-against-wild-type-and-drug-resistant-hiv-1-strains-2/ 2022-02-22T14:01:26+00:00 https://www.irbm.com/scientific-publications/publications-2018/identification-of-novel-multi-stage-histone-deacetylase-hdac-inhibitors-that-impair-schistosoma-mansoni-viability-and-egg-production/ 2022-02-22T14:01:35+00:00 https://www.irbm.com/scientific-publications/publications-2018/identification-and-binding-mode-of-a-novel-leishmania-trypanothione-reductase-inhibitor-from-high-throughput-screening/ 2022-02-22T14:01:42+00:00 https://www.irbm.com/scientific-publications/publications-2018/dna-replication-and-repair-kinetics-of-alu-line-1-and-satellite-iii-genomic-repetitive-elements/ 2022-02-22T14:01:48+00:00 https://www.irbm.com/scientific-publications/publications-2018/fosmetpantotenate-re-024-a-phosphopantothenate-replacement-therapy-for-pantothenate-kinase-associated-neurodegeneration-mechanism-of-action-and-efficacy-in-nonclinical-models/ 2022-02-22T14:02:09+00:00 https://www.irbm.com/scientific-publications/publications-2018/determination-of-acetyl-coenzyme-a-in-human-whole-blood-by-ultra-performance-liquid-chromatography-mass-spectrometry/ 2022-02-22T14:02:19+00:00 https://www.irbm.com/scientific-publications/publications-2018/quantifying-autophagy-using-novel-lc3b-and-p62-tr-fret-assays/ 2022-02-22T14:02:27+00:00 https://www.irbm.com/scientific-publications/publications-2018/peptidomimetic-nitrile-inhibitors-of-malarial-protease-falcipain-2-with-high-selectivity-against-human-cathepsins/ 2022-02-22T14:02:34+00:00 https://www.irbm.com/scientific-publications/publications-2018/early-metabolic-response-to-acute-myocardial-ischaemia-in-patients-undergoing-elective-coronary-angioplasty/ 2022-02-22T14:02:42+00:00 https://www.irbm.com/scientific-publications/publications-2018/development-of-a-broadly-applicable-assay-for-measurement-of-glycan-directed-enzymatic-activity/ 2022-02-22T14:02:49+00:00 https://www.irbm.com/scientific-publications/publications-2018/a-liquid-chromatography-high-resolution-mass-spectrometry-in-vitro-assay-to-assess-metabolism-at-the-injection-site-of-subcutaneously-administered-therapeutic-peptides/ 2022-02-22T14:02:56+00:00 https://www.irbm.com/scientific-publications/publications-2019/synthesis-and-evaluation-of-bifunctional-aminothiazoles-as-antiretrovirals-targeting-the-hiv-1-nucleocapsid-protein/ 2022-02-22T14:56:59+00:00 https://www.irbm.com/scientific-publications/publications-2019/sulphide-as-a-leaving-group-highly-stereoselective-bromination-of-alkyl-phenyl-sulphides/ 2022-02-22T14:57:09+00:00 https://www.irbm.com/scientific-publications/publications-2019/improved-selective-class-i-hdac-and-novel-selective-hdac3-inhibitors-beyond-hydroxamic-acids-and-benzamides/ 2022-02-22T14:57:17+00:00 https://www.irbm.com/wp-content/uploads/34-beyond-hydroxamic-acids-benzamides.png https://www.irbm.com/scientific-publications/publications-2019/frataxin-structure-and-function/ 2022-02-22T14:57:25+00:00 https://www.irbm.com/scientific-publications/publications-2019/an-ig-transmembrane-domain-motif-improves-the-function-of-tcrs-transduced-in-human-t-cells-implications-for-immunotherapy/ 2022-02-22T14:57:32+00:00 https://www.irbm.com/scientific-publications/publications-2019/bromoindirubin-3-oxime-intercepts-gsk3-signaling-to-promote-and-enhance-skeletal-muscle-differentiation-affecting-mir-206-expression-in-mice/ 2022-02-22T14:57:40+00:00 https://www.irbm.com/scientific-publications/publications-2019/synthesis-and-biological-evaluation-of-rgd%e2%81%bbcryptophycin-conjugates-for-targeted-drug-delivery/ 2022-02-22T14:58:04+00:00 https://www.irbm.com/scientific-publications/publications-2019/design-synthesis-and-biological-evaluation-of-new-1-aryl-1-h-pyrrolylphenylmethyl-1-h-imidazole-derivatives-as-antiprotozoal-agent/ 2022-02-22T14:58:15+00:00 https://www.irbm.com/scientific-publications/publications-2019/inhibiting-pathologically-active-adam10-rescues-synaptic-and-cognitive-decline-in-huntingtons-disease/ 2022-02-22T14:58:23+00:00 https://www.irbm.com/scientific-publications/publications-2019/octreotide-conjugates-for-tumor-targeting-and-imaging/ 2022-02-22T14:58:30+00:00 https://www.irbm.com/scientific-publications/publications-2019/a-novel-member-of-prame-family-gm12794c-counteracts-retinoic-acid-differentiation-through-the-methyltransferase-activity-of-prc2/ 2022-02-22T14:58:38+00:00 https://www.irbm.com/scientific-publications/publications-2019/collagen-prolyl-hydroxylation-dependent-metabolic-perturbation-governs-epigenetic-remodeling-and-mesenchymal-transition-in-pluripotent-and-cancer-cells/ 2022-02-22T14:58:47+00:00 https://www.irbm.com/wp-content/uploads/27-collagen-prolyl-2019.jpg https://www.irbm.com/scientific-publications/publications-2019/the-outcomes-of-decorated-prolines-in-the-discovery-of-antimicrobial-peptides-from-temporin-l/ 2022-02-22T14:58:56+00:00 https://www.irbm.com/scientific-publications/publications-2019/development-and-characterization-of-cellular-biosensors-for-hts-of-erythroid-differentiation-inducers-targeting-the-transcriptional-activity-of-%ce%b3-globin-and-%ce%b2-globin-gene-promoters/ 2022-02-22T14:59:06+00:00 https://www.irbm.com/wp-content/uploads/29-biosensors-for-HTS-2019.jpg https://www.irbm.com/scientific-publications/publications-2019/salivary-metabolome-and-soccer-match-challenges-for-understanding-exercise-induced-changes/ 2022-02-22T14:59:14+00:00 https://www.irbm.com/scientific-publications/publications-2019/fish-derived-antimicrobial-peptides-activity-of-a-chionodracine-mutant-against-bacterial-models-and-human-bacterial-pathogens/ 2022-02-22T14:59:20+00:00 https://www.irbm.com/scientific-publications/publications-2019/aspergillus-olivimuriae-sp-nov-a-halotolerant-species-isolated-from-olive-brine/ 2022-02-22T14:59:34+00:00 https://www.irbm.com/scientific-publications/publications-2019/multiple-synthetic-routes-to-the-mini-protein-omomyc-and-coiled-coil-domain-truncations/ 2022-02-22T14:59:53+00:00 https://www.irbm.com/scientific-publications/publications-2019/developmental-abnormalities-in-cortical-gabaergic-system-in-mice-lacking-mglu3-metabotropic-glutamate-receptors/ 2022-02-22T15:00:01+00:00 https://www.irbm.com/scientific-publications/publications-2020/the-mirnas-role-in-melanoma-and-in-its-resistance-to-therapy/ 2022-02-22T17:00:43+00:00 https://www.irbm.com/scientific-publications/publications-2020/synthesis-and-antiproliferative-activity-of-nitric-oxide-donor-largazole-prodrugs/ 2022-02-22T17:00:53+00:00 https://www.irbm.com/scientific-publications/publications-2020/luminescence-based-low-and-medium-throughput-assays-for-drug-screening-in-schistosoma-mansoni-larval-stage/ 2022-02-22T17:01:19+00:00 https://www.irbm.com/scientific-publications/publications-2020/discovery-of-the-first-human-arylsulfatase-a-reversible-inhibitor-impairing-mouse-oocyte-fertilization/ 2022-02-22T17:01:27+00:00 https://www.irbm.com/scientific-publications/publications-2020/discovery-and-preliminary-characterization-of-translational-modulators-that-impair-the-binding-of-eif6-to-60s-ribosomal-subunits/ 2022-02-22T17:01:37+00:00 https://www.irbm.com/scientific-publications/publications-2020/a-novel-member-of-prame-family-gm12794c-counteracts-retinoic-acid-differentiation-through-the-methyltransferase-activity-of-prc2-2/ 2022-02-22T17:01:48+00:00 https://www.irbm.com/scientific-publications/publications-2020/dihydroxypyrimidine-scaffold-to-target-hiv%e2%80%911-nucleocapsid-protein/ 2022-02-22T17:03:19+00:00 https://www.irbm.com/wp-content/uploads/irbm-hiv-1-nucleocapsid-protein-EU2.jpg https://www.irbm.com/wp-content/uploads/irbm-hiv-1-nucleocapsid-protein.png https://www.irbm.com/scientific-contributions/irbm-university-of-rome-publishes-in-nature-on-crucial-signaling-pathway-in-muscle-homeostasis-and-regeneration/ 2022-02-22T17:03:52+00:00 https://www.irbm.com/wp-content/uploads/irbm-muscle-homeostasis.jpg https://www.irbm.com/scientific-contributions/irbm-publishes-on-optimizing-a-new-series-of-trypanosoma-brucei-growth-inhibitors-the-parasite-responsible-of-the-sleeping-sickness/ 2022-02-22T17:04:01+00:00 https://www.irbm.com/wp-content/uploads/IRBM-Trypanosoma-brucei.jpg https://www.irbm.com/scientific-contributions/irbm-university-of-rome-publishes-in-plos-on-new-chemotype-with-antiparasitic-activity-for-treating-sleeping-sickness/ 2022-02-22T17:04:09+00:00 https://www.irbm.com/wp-content/uploads/IRBM-PLOS-on-new-chemotype.jpg https://www.irbm.com/wp-content/uploads/IRBM-PLOS-on-new-chemotype.jpg https://www.irbm.com/scientific-contributions/irbm-publishes-in-j-peptide-science-on-methods-to-study-catabolism-key-to-designing-more-stable-peptides/ 2022-02-22T17:04:18+00:00 https://www.irbm.com/wp-content/uploads/irbm-publication-catabolism3.jpg https://www.irbm.com/scientific-publications/publications-2020/optimization-of-linear-and-cyclic-peptide-inhibitors-of-keap1-nrf2-protein-protein-interaction/ 2022-02-22T17:04:41+00:00 https://www.irbm.com/scientific-publications/publications-2020/analysis-of-mutant-and-total-huntingtin-expression-in-huntingtons-disease-murine-models/ 2022-02-22T17:06:18+00:00 https://www.irbm.com/scientific-publications/publications-2020/nrf2-activation-by-reversible-keap1-binding-induces-the-antioxidant-response-in-primary-neurons-and-astrocytes-of-a-huntingtons-disease-mouse-model/ 2022-02-22T17:06:25+00:00 https://www.irbm.com/wp-content/uploads/irbm-elsevier-free-radical-paper.jpg https://www.irbm.com/scientific-contributions/irbm-cited-in-uniqure-publication-on-using-htt-lowering-therapies-to-slow-down-neurodegeneration-in-huntingtons-disease/ 2022-02-23T08:42:54+00:00 https://www.irbm.com/wp-content/uploads/irbm-htt-lowering-therapies-huntington-disease8.jpg https://www.irbm.com/scientific-contributions/oligomerization-albumin-binding-and-catabolism-of-therapeutic-peptides-in-the-subcutaneous-compartment-an-investigation-on-lipidated-glp-1-analogs/ 2022-02-23T09:37:26+00:00 https://www.irbm.com/wp-content/uploads/irbm-Oligomerization-albumin-binding-catabolism-therapeutic-peptides-2.jpg https://www.irbm.com/scientific-publications/publications-2021/irbm-heidelberg-university-hospital-publishes-in-cell-reports-medicine-on-kynurenine-pathway-activation-and-deviation-to-anthranilic-and-kynurenic-acid-in-fibrosing-chronic-graft-versus-host-disease/ 2022-03-02T08:43:07+00:00 https://www.irbm.com/wp-content/uploads/IRBM-Heidelberg-University-Hospital-3.jpg https://www.irbm.com/scientific-publications/publications-2022/development-of-protx-ii-analogues-as-highly-selective-peptide-blockers-of-nav1-7-for-the-treatment-of-pain/ 2022-03-02T08:44:23+00:00 https://www.irbm.com/wp-content/uploads/Development-of-ProTx-II-Analogues-as-Highly-Selective-Peptide-Blockers-of-Nav1.7-for-the-Treatment-of-Pain.jpg https://www.irbm.com/scientific-publications/publications-2020/irbm-publishes-in-nature-scientific-reports-on-the-janus-effect-of-glucocorticoids-on-the-differentiation-of-muscle-fibro-adipogenic-progenitors/ 2022-03-04T15:32:01+00:00 https://www.irbm.com/wp-content/uploads/IRBM_irbm.jpg https://www.irbm.com/scientific-publications/publications-2019/identification-of-isoform-2-acid-sensing-ion-channel-inhibitors-as-tool-compounds-for-target-validation-studies-in-cns/ 2022-03-04T15:34:17+00:00 https://www.irbm.com/scientific-publications/publications-2019/a-novel-method-using-nuclear-magnetic-resonance-for-plasma-proteinbinding-assessment-in-drug-discovery-programs/ 2022-03-04T15:35:18+00:00 https://www.irbm.com/scientific-contributions/irbm-gen-cell-imaging/ 2022-03-23T09:40:02+00:00 https://www.irbm.com/wp-content/uploads/IRBM-GEN-Cell-Imaging.jpg https://www.irbm.com/scientific-publications/publications-2022/efficacy-of-pegylated-ciliary-neurotrophic-factor-superagonist-variant-in-diet-induced-obesity-mice/ 2022-03-29T12:44:07+00:00 https://www.irbm.com/wp-content/uploads/Effect-on-body-weight-and-food-intake-of-short-term-administration-of-DH-CNTF-and-PEG-DH-CNTF-in-DIO-mice-3.jpg https://www.irbm.com/press-review/under-the-microscope-exploring-phage-display-technologies-for-drug-discovery-and-early-development/ 2022-05-19T09:54:36+00:00 https://www.irbm.com/press-review/irbms-elisabetta-bianchi-talks-about-peptide-chemistry/ 2022-05-20T13:00:25+00:00 https://www.irbm.com/news/discovery-of-4-1-1h-imidazol-2-ylalkoxymethylpyridines-as-a-new-class-of-trypanosoma-cruzi-growth-inhibitors/ 2023-05-16T10:37:56+00:00 https://www.irbm.com/wp-content/uploads/Triatoma_brasiliensis_IRBM-publications.jpg https://www.irbm.com/news/eib-provides-e15-million-to-fund-coronavirus-research-at-irbm/ 2023-05-23T08:00:52+00:00 https://www.irbm.com/wp-content/uploads/IRBM-EIB-coronavirus-research-2.jpg https://www.irbm.com/news/targeting-of-eif6-driven-translation-induces-a-metabolic-rewiring-that-reduces-nafld-and-the-consequent-evolution-to-hepatocellular-carcinoma/ 2023-05-23T08:02:23+00:00 https://www.irbm.com/wp-content/uploads/irbm-nature-communications-eIF6-paper-2.jpg https://www.irbm.com/news/irbm-collaborators-publish-on-techniques-for-characterizing-peptides-in-type-2-diabetes-and-a-peptide-drug-discovery-program-for-huntingtons-disease/ 2023-05-23T08:02:39+00:00 https://www.irbm.com/wp-content/uploads/irbm_diabetes-peptide1_1280x730.jpg https://www.irbm.com/scientific-contributions/identification-of-potent-and-long-acting-single-chain-peptide-mimetics-of-human-relaxin-2-for-cardiovascular-diseases/ 2023-06-04T17:25:07+00:00 https://www.irbm.com/wp-content/uploads/IRBM-Sanofi-publication.jpg https://www.irbm.com/press-releases/antios-therapeutics-announces-agreement-with-irbm-ingm-and-osr-to-acquire-fourth-generation-hbv-capsid-assembly-modulators-cams/ 2023-06-26T08:33:40+00:00 https://www.irbm.com/wp-content/uploads/Antios-Therapeutics-Agreement-IRBM-INGM-OSR-2_1280x730-1.jpg https://www.irbm.com/webinars/peptide-therapeutics-why-early-implementation-of-a-screening-funnel-is-the-key-to-success/ 2023-08-29T09:00:04+00:00 https://www.irbm.com/webinars/biomarkers-for-neurodegenerative-diseases-immunoassays-and-lc-ms-ms-to-track-disease-progression-2/ 2023-08-29T09:03:31+00:00 https://www.irbm.com/scientific-contributions/a-series-of-novel-highly-potent-and-orally-bioavailable-next-generation-tricyclic-peptide-pcsk9-inhibitors/ 2023-09-08T13:19:32+00:00 https://www.irbm.com/wp-content/uploads/irbm-Tricyclic-Peptide-PCSK9-Inhibitors-1.jpg https://www.irbm.com/scientific-contributions/combined-peptide-and-small-molecule-approach-toward-nonacidic-thiq-inhibitors-of-the-keap1-nrf2-interaction/ 2023-09-08T13:27:34+00:00 https://www.irbm.com/wp-content/uploads/nrf2-are.jpg https://www.irbm.com/press-releases/irbm-extends-peptide-therapeutics-collaboration-with-merck-co-inc-rahway-nj-usa/ 2023-10-25T13:51:42+00:00 https://www.irbm.com/wp-content/uploads/Merck-contract-ext.webp https://www.irbm.com/senza-categoria/orally-bioavailable-macrocyclic-peptide-that-inhibits-binding-of-pcsk9-to-the-low-density-lipoprotein-receptor/ 2023-10-25T13:51:42+00:00 https://www.irbm.com/wp-content/uploads/IRBM-Orally-Bioavailable-Macrocyclic-Peptide.webp https://www.irbm.com/press-releases/irbm-rainwater-charitable-foundation-and-weill-cornell-medicine-join-forces-to-progress-therapies-for-neurodegenerative-disorders/ 2023-10-26T12:57:56+00:00 https://www.irbm.com/wp-content/uploads/Rainwater-charitable-foundation-1.webp https://www.irbm.com/news/irbm-selected-for-participation-in-national-chemical-biology-consortium/ 2023-10-26T12:58:49+00:00 https://www.irbm.com/wp-content/uploads/irbm-1-center-81280x730-1-430x250@2x.webp https://www.irbm.com/news/irbm-world-cancer-day-head-of-oncology/ 2023-10-26T12:59:32+00:00 https://www.irbm.com/wp-content/uploads/carugo-head-of-oncology_1280x730.jpg https://www.irbm.com/senza-categoria/from-marine-natural-products-to-macrocyclic-peptidomimetics/ 2023-10-26T13:01:17+00:00 https://www.irbm.com/wp-content/uploads/irbm-prof-irene-izzo-1.webp https://www.irbm.com/scientific-contributions/irbm-publish-malaria-breakthrough-research-in-nature-communications-biology/ 2024-02-21T11:55:31+00:00 https://www.irbm.com/wp-content/uploads/IRBM-malaria-breakthrough-research-Nature-Communications-Biology-center-1280x730-1.jpg https://www.irbm.com/scientific-publications/orally-bioavailable-macrocyclic-peptide-that-inhibits-binding-of-pcsk9-to-the-low-density-lipoprotein-receptor-2/ 2024-02-22T16:50:17+00:00 https://www.irbm.com/wp-content/uploads/Orally-Bioavailable-Macrocyclic-Peptide-That-Inhibits-Binding-of-PCSK9-to-the-Low-Density-Lipoprotein-Receptor_May-1-2023.png https://www.irbm.com/wp-content/uploads/MK-0616.jpg https://www.irbm.com/events/discovery-europe-neuroscience-drug-development-europe2024-oxford-global/ 2024-02-23T09:07:31+00:00 https://www.irbm.com/wp-content/uploads/15_Discovery_Europe2024.webp https://www.irbm.com/events/slas-eu/ 2024-02-23T09:07:54+00:00 https://www.irbm.com/wp-content/uploads/16_SLAS_Europe2024.webp https://www.irbm.com/events/drug-discovery-chemistry/ 2024-02-23T09:08:56+00:00 https://www.irbm.com/wp-content/uploads/7_DDC2024.webp https://www.irbm.com/events/aacr/ 2024-02-23T09:09:25+00:00 https://www.irbm.com/wp-content/uploads/8_AACR2024.webp https://www.irbm.com/events/acsmedi-efmc-medicinal-chemistry-frontiers/ 2024-02-23T09:09:44+00:00 https://www.irbm.com/wp-content/uploads/9_EFMC_ACSMEDI2024.webp https://www.irbm.com/events/new-modalities-innovations-in-peptides-as-biotherapeutics/ 2024-02-23T09:10:09+00:00 https://www.irbm.com/wp-content/uploads/10_New_Modalities2024.webp https://www.irbm.com/events/slas/ 2024-02-23T09:11:52+00:00 https://www.irbm.com/wp-content/uploads/2_SLAS2024.webp https://www.irbm.com/events/acs-spring-the-many-flavors-of-chemistry/ 2024-02-23T09:12:14+00:00 https://www.irbm.com/wp-content/uploads/4_ACSSpring2024.webp https://www.irbm.com/events/tpd-targeted-protein-degradation-europe-2024/ 2024-02-23T09:12:45+00:00 https://www.irbm.com/wp-content/uploads/6_TPD_Europe2024.webp https://www.irbm.com/events/cbc-nci-meeting/ 2024-02-23T09:12:59+00:00 https://www.irbm.com/wp-content/uploads/1_CBC-NCI-meeting2024.webp https://www.irbm.com/events/chdi/ 2024-02-23T09:19:14+00:00 https://www.irbm.com/wp-content/uploads/3_CHDI_2024.webp https://www.irbm.com/news/irbm-recognized-at-the-44th-annual-edison-patent-awards/ 2024-02-27T08:57:02+00:00 https://www.irbm.com/wp-content/uploads/IRBM-NEWS_44th-annual-edison-patent-awards_v4-scaled.jpg https://www.irbm.com/wp-content/uploads/44th-Annual-Edison-Awards-Ceremony.jpg https://www.irbm.com/scientific-publications/publication-2023/the-urine-metabolome-of-r6-2-and-zq175dn-huntingtons-disease-mouse-models/ 2024-03-05T13:38:47+00:00 https://www.irbm.com/wp-content/uploads/Urine-metabolome-of-R62-and-Q175DN-Huntingtons-Disease-Mouse-Models.png https://www.irbm.com/press-releases/irbm-expands-global-reach-in-drug-discovery-with-new-boston-office/ 2024-03-05T14:47:29+00:00 https://www.irbm.com/wp-content/uploads/PR_NEW-BOSTON-OFFICE-scaled.jpg https://www.irbm.com/news/advancing-integrated-drug-discovery-irbms-strategic-role-at-bio-europe-spring-2024-in-barcelona/ 2024-03-11T11:19:23+00:00 https://www.irbm.com/wp-content/uploads/IRBM-NEWS_BIO-EUROPE-SPRING-scaled.jpg https://www.irbm.com/events/bio-europe-spring-2/ 2024-04-02T12:52:43+00:00 https://www.irbm.com/wp-content/uploads/5_Bio_Europe_spring2024-1.webp https://www.irbm.com/events/european-peptide-synthesis-conference/ 2024-04-10T10:38:41+00:00 https://www.irbm.com/wp-content/uploads/11_EPSC2024.webp https://www.irbm.com/press-releases/irbm-to-disclose-strong-antitumor-efficacy-of-novel-preclinical-agents-against-aggressive-brain-tumors-and-acute-lymphoblastic-leukemia-at-aacr/ 2024-04-11T08:41:05+00:00 https://www.irbm.com/wp-content/uploads/PR_DATA-DISCLOSURE-AACR-2024-scaled.jpg https://www.irbm.com/news/recap-irbm-innovations-cancer-research-aacr-2024/ 2024-04-18T07:23:52+00:00 https://www.irbm.com/wp-content/uploads/AACR-2024-RECAP_FINAL.svg https://www.irbm.com/scientific-article/shp2-inhibitors-progress-in-2024/ 2024-04-24T12:36:34+00:00 https://www.irbm.com/wp-content/uploads/IRBM-ARTICLE_SHP2-in-2024_v4.svg https://www.irbm.com/wp-content/uploads/SHP2_FIGURE_1.svg https://www.irbm.com/events/pegs/ 2024-05-28T14:58:35+00:00 https://www.irbm.com/wp-content/uploads/12_PEGS_Boston2024.webp https://www.irbm.com/events/tides-us/ 2024-05-28T15:48:35+00:00 https://www.irbm.com/wp-content/uploads/13_TIDES_USA.webp https://www.irbm.com/scientific-publications/publications-2020/irbm-chdi-foundation-publishes-in-j-medchem-on-potential-imaging-biomarker-for-huntingtons-disease/ 2024-06-10T11:26:40+00:00 https://www.irbm.com/wp-content/uploads/hdi-CHDI-Foundation.jpg https://www.irbm.com/events/bio-international/ 2024-06-26T08:01:48+00:00 https://www.irbm.com/wp-content/uploads/17_Bio_International2024.webp https://www.irbm.com/events/icar-international-society-for-antiviral-research/ 2024-06-26T13:03:47+00:00 https://www.irbm.com/wp-content/uploads/14_ICAR2024.webp https://www.irbm.com/events/euromar-2024/ 2024-06-27T10:36:16+00:00 https://www.irbm.com/wp-content/uploads/EUROMAR-2024_EVENTS-LIST.svg https://www.irbm.com/events/3rd-international-spatial-biology-congress-europe-2024/ 2024-06-27T10:36:24+00:00 https://www.irbm.com/wp-content/uploads/3rd-International-Spatial-Biology-Congress_-Europe_EVENTS-LIST.svg https://www.irbm.com/press-releases/advancing-pharmaceutical-innovation-3-way-agreement-irbm-campus-bio-medico/ 2024-08-12T13:33:11+00:00 https://www.irbm.com/wp-content/uploads/IRBM-UCBM-COLLAB-2024_final-scaled.jpg https://www.irbm.com/wp-content/uploads/20240327_Firma_IRBM_UCBM_02-scaled.jpg https://www.irbm.com/events/immuno-oncology2024/ 2024-08-13T09:08:07+00:00 https://www.irbm.com/wp-content/uploads/Immuno-Oncology-Summit_EVENTS-LIST.svg https://www.irbm.com/scientific-publications/publications-2022/guiding-chemically-synthesized-peptide-drug-lead-optimization-by-de-risking-mast-cell-degranulation-related-toxicities-of-a-nav1-7-peptide-inhibitor/ 2024-08-22T12:41:03+00:00 https://www.irbm.com/wp-content/uploads/Guiding-chemically-synthesized-peptide-drug-lead-optimization-by-de-risking-mast-cell-degranulation-related-toxicities-of-a-NaV1.7-peptide-inhibitor-ok.jpg https://www.irbm.com/events/eps-ips-2024/ 2024-08-30T15:04:56+00:00 https://www.irbm.com/wp-content/uploads/EPS-IPS-2024_EVENTS-LIST.svg https://www.irbm.com/events/icmrbs-2024-2/ 2024-09-02T09:35:35+00:00 https://www.irbm.com/wp-content/uploads/ICMRBS-2024_EVENTS-LIST.svg https://www.irbm.com/news/irbm-group-achieves-gold-rating-for-sustainability-from-ecovadis/ 2024-09-03T15:12:01+00:00 https://www.irbm.com/wp-content/uploads/EcoVadis-IRBM-Cover_2.0.webp https://www.irbm.com/events/efmc-ismc-2024/ 2024-09-05T13:49:17+00:00 https://www.irbm.com/wp-content/uploads/EFMC-ISMC-2024_EVENTS-LIST.svg https://www.irbm.com/events/ehdn-enroll-hd-2024/ 2024-09-16T13:20:46+00:00 https://www.irbm.com/wp-content/uploads/EHDN-Enroll-HD-2024.png https://www.irbm.com/events/dipia2024/ 2024-09-19T09:14:41+00:00 https://www.irbm.com/wp-content/uploads/DiPIA-2024-1.png https://www.irbm.com/events/inf-act-meeting-2024/ 2024-09-19T09:15:11+00:00 https://www.irbm.com/wp-content/uploads/INF-ACT-meeting-2024.png https://www.irbm.com/events/bpf-boulder-peptide-2024/ 2024-09-19T09:15:57+00:00 https://www.irbm.com/wp-content/uploads/BPS-2024.png https://www.irbm.com/events/nls-days-2024/ 2024-09-23T13:55:31+00:00 https://www.irbm.com/wp-content/uploads/NLSDays-2024.png https://www.irbm.com/events/ddip-drug-discovery-innovation-program-2024/ 2024-09-23T13:55:41+00:00 https://www.irbm.com/wp-content/uploads/DDIP-2024.png https://www.irbm.com/events/sic-2024/ 2024-10-02T13:23:43+00:00 https://www.irbm.com/wp-content/uploads/SIC-MILANO-2024.png https://www.irbm.com/events/euroqsar2024/ 2024-10-02T13:23:50+00:00 https://www.irbm.com/wp-content/uploads/EuroQSAR-2024.png https://www.irbm.com/events/drug-discovery-2024/ 2024-10-09T12:25:33+00:00 https://www.irbm.com/wp-content/uploads/DRUG-DISCOVERY-2024.png https://www.irbm.com/events/spica2024/ 2024-10-18T08:49:57+00:00 https://www.irbm.com/wp-content/uploads/SPICA-2024.png https://www.irbm.com/events/slas-2024/ 2024-10-18T08:50:06+00:00 https://www.irbm.com/wp-content/uploads/SLAS-2024.png https://www.irbm.com/events/vancouver-pbss-2024/ 2024-10-28T09:12:16+00:00 https://www.irbm.com/wp-content/uploads/PBSS-2024.png https://www.irbm.com/events/eortc-nci-aacr-2024/ 2024-10-28T09:15:37+00:00 https://www.irbm.com/wp-content/uploads/EORTC-NCI-AACR-2024.png https://www.irbm.com/events/bio-europe-2024/ 2024-11-08T14:00:44+00:00 https://www.irbm.com/wp-content/uploads/BIO-EUROPE-2024.png https://www.irbm.com/scientific-publications/publications-2024/lc-ms-ms-assay-for-heparan-n-sulphatase-in-paediatric-csf-a-potential-pharmacodynamic-biomarker-for-mucopolysaccharidosis-type-iiia-therapy/ 2024-11-19T12:41:49+00:00 https://www.irbm.com/wp-content/uploads/ClinicaClinicaActa-Cover-.webp https://www.irbm.com/senza-categoria/unlock-the-potential-of-spatial-biology-in-drug-discovery/ 2024-11-19T14:54:55+00:00 https://www.irbm.com/wp-content/uploads/White-Paper_SpatialBiology_Website_cover.jpg https://www.irbm.com/events/18th-naples-workshop-on-bioactive-peptides-2024-2/ 2024-12-23T16:53:10+00:00 https://www.irbm.com/wp-content/uploads/ESSB-2024.png https://www.irbm.com/events/18th-naples-workshop-on-bioactive-peptides-2024/ 2024-12-23T16:53:36+00:00 https://www.irbm.com/wp-content/uploads/18th-Naples-Workshop-on-Bioactive-Peptides-2024.png https://www.irbm.com/scientific-publications/publications-2009/histone-deacetylase-inhibitors-with-a-primary-amide-zinc-binding-group-display-antitumor-activity-in-xenograft-model/ 2024-12-31T10:43:54+00:00 https://www.irbm.com/scientific-contributions/irbms-publishes-in-cells-on-establishing-a-human-blood-brain-barrier-model-for-use-in-drug-discovery-for-neurodegenerative-diseases-such-as-huntingtons/ 2024-12-31T13:09:28+00:00 https://www.irbm.com/wp-content/uploads/cover-cells-v9-i4.webp https://www.irbm.com/scientific-publications/publications-2019/application-of-an-in-vitro-blood%e2%88%92brain-barrier-model-in-the-selection-of-experimental-drug-candidates-for-the-treatment-of-huntingtons-disease/ 2024-12-31T13:17:10+00:00 https://www.irbm.com/wp-content/uploads/Molecular-Pharmaceutics-Cover.jpg https://www.irbm.com/wp-content/uploads/IRBM-Blood%E2%80%93Brain-Barrier-Model.png https://www.irbm.com/scientific-publications/publications-2019/whole-genome-phage-display-libraries-a-powerful-tool-for-antigen-discovery/ 2024-12-31T13:30:54+00:00 https://www.irbm.com/wp-content/uploads/Immuno-proteomics_cover-1.jpg https://www.irbm.com/scientific-publications/publications-2018/polypharmacy-through-phage-display-selection-of-glucagon-and-glp-1-receptor-co-agonists-from-a-phage-displayed-peptide-library/ 2024-12-31T13:42:47+00:00 https://www.irbm.com/wp-content/uploads/Scientific-Reports-Nature_Journal_Cover.jpg https://www.irbm.com/scientific-contributions/series-of-novel-and-highly-potent-cyclic-peptide-pcsk9-inhibitors-derived-from-an-mrna-display-screen-and-optimized-via-structure-based-design/ 2024-12-31T14:22:09+00:00 https://www.irbm.com/wp-content/uploads/Journal-of-medicinal-chemistry_cover.jpg https://www.irbm.com/scientific-publications/publications-2024/a-patent-review-of-shp2-allosteric-inhibitors-2024/ 2024-12-31T14:45:26+00:00 https://www.irbm.com/wp-content/uploads/Expert-Opinion-on-Therapeutic-Patents.png https://www.irbm.com/scientific-publications/publications-2024/direct-to-biology-platform-shp2-allosteric-inhibitors/ 2024-12-31T15:32:14+00:00 https://www.irbm.com/wp-content/uploads/Biorganic-Medicinal-Chemistry-Letters.jpg https://www.irbm.com/scientific-publications/discovery-of-a-novel-series-of-imidazopyrazine-derivatives-as-potent-shp2-allosteric-inhibitors/ 2024-12-31T15:51:43+00:00 https://www.irbm.com/wp-content/uploads/ACS-Medicinal-Chemistry-Letters-Volume-14-Issue-2_cover.png https://www.irbm.com/scientific-publications/publication-2023/discovery-of-a-novel-series-of-imidazopyrazine-derivatives-as-potent-shp2-allosteric-inhibitors-2/ 2024-12-31T16:08:48+00:00 https://www.irbm.com/wp-content/uploads/ACS-MED-CHEM-LETTERS-MAY-2023.png https://www.irbm.com/scientific-publications/publications-2020/a-spectroscopic-and-molecular-dynamics-study-on-the-aggregation-process-of-a-long-acting-lipidated-therapeutic-peptide-the-case-of-semaglutide/ 2024-12-31T16:32:47+00:00 https://www.irbm.com/wp-content/uploads/Soft-Matter-Cover_upscale3.0.png https://www.irbm.com/scientific-publications/publications-2010/a-vaccine-targeting-telomerase-enhances-survival-of-dogs-affected-by-b-cell-lymphoma/ 2024-12-31T16:39:40+00:00 https://www.irbm.com/wp-content/uploads/Molecular-Therapy_cover.jpg https://www.irbm.com/scientific-publications/publications-2022/sar-evolution-towards-potent-c-terminal-carboxamide-peptide-inhibitors-of-zika-virus-ns2b-ns3-protease/ 2025-01-20T17:16:21+00:00 https://www.irbm.com/wp-content/uploads/Biorganic-medical-chemistry.png https://www.irbm.com/events/slas-2025-san-diego/ 2025-02-03T13:08:32+00:00 https://www.irbm.com/wp-content/uploads/Banner-SLAS-25.png https://www.irbm.com/scientific-publications/publications-2020/ring-finger-protein-11-acts-on-ligand-activated-egfr-via-the-direct-interaction-with-the-uim-region-of-ankrd13-protein-family/ 2025-02-24T11:15:36+00:00 https://www.irbm.com/wp-content/uploads/Febs-Journal.v287.16.cover_.jpg https://www.irbm.com/events/chdi-forum-2025-palm-springs/ 2025-02-28T09:30:47+00:00 https://www.irbm.com/wp-content/uploads/CHDI-2025.png https://www.irbm.com/events/bio-europe-spring-2025-milan/ 2025-03-20T09:38:38+00:00 https://www.irbm.com/wp-content/uploads/Bio-Europe-Spring2025.png https://www.irbm.com/events/icar-2025-las-vegas/ 2025-03-26T16:04:23+00:00 https://www.irbm.com/wp-content/uploads/ICAR2025.png https://www.irbm.com/scientific-publications/publications-2025/de-novo-discovery-of-cyclic-peptide-inhibitors-of-il-11-signaling/ 2025-04-03T10:06:28+00:00 https://www.irbm.com/wp-content/uploads/Bioorganic-Medicinal-Chemistry-_Volume-100.png https://www.irbm.com/events/ecv-european-congress-of-virology-2025-dubrovnik/ 2025-04-29T13:18:25+00:00 https://www.irbm.com/wp-content/uploads/ECV2025.png https://www.irbm.com/events/accr-annual-meeting-2025-chicago/ 2025-04-30T13:33:21+00:00 https://www.irbm.com/wp-content/uploads/AACR-2025.png https://www.irbm.com/events/swiss-biotech-day-2025/ 2025-05-06T09:29:49+00:00 https://www.irbm.com/wp-content/uploads/Swiss-Biotech.png https://www.irbm.com/events/acsmedi-efmc-medicinal-chemistry-frontiers-2025-chicago/ 2025-05-15T13:55:25+00:00 https://www.irbm.com/wp-content/uploads/ACSMEDI-EFMC.png https://www.irbm.com/events/tides-usa-2025-san-diego/ 2025-05-23T10:55:27+00:00 https://www.irbm.com/wp-content/uploads/TIDES.png https://www.irbm.com/events/antibody-engineering-therapeutics-europe-2025-basel/ 2025-06-13T08:49:57+00:00 https://www.irbm.com/wp-content/uploads/Antibody-2025.png https://www.irbm.com/events/aps-2025-san-diego/ 2025-06-19T08:30:55+00:00 https://www.irbm.com/wp-content/uploads/APS-2025.png https://www.irbm.com/events/bio-international-2025-boston/ 2025-06-20T09:17:27+00:00 https://www.irbm.com/wp-content/uploads/Bio-International-2025.png https://www.irbm.com/events/discoverydevelopment-europe-basil-2025/ 2025-06-26T10:26:22+00:00 https://www.irbm.com/wp-content/uploads/DiscoveryDevelopment-2025-1.png https://www.irbm.com/events/immuno-oncology-summit-2025/ 2025-08-13T09:31:37+00:00 https://www.irbm.com/wp-content/uploads/Immuno-Oncology-Summit_2025.png https://www.irbm.com/events/epsc-2025/ 2025-08-27T14:29:26+00:00 https://www.irbm.com/wp-content/uploads/EPSC-2025.png https://www.irbm.com/scientific-publications/publications-2019/omomyc-reveals-new-mechanisms-to-inhibit-the-myc-oncogene/ 2025-08-29T15:24:19+00:00 https://www.irbm.com/scientific-publications/publications-2020/multiple-synthetic-routes-to-the-mini-protein-omomyc-and-coiled-coil-domain-truncations-2/ 2025-08-29T15:25:36+00:00 https://www.irbm.com/scientific-publications/publications-2022/novel-gametocyte-specific-and-all-blood-stage-transmission-blocking-chemotypes-from-high-throughput-screening-on-plasmodium-falciparum-gametocytes/ 2025-08-29T15:26:19+00:00 https://www.irbm.com/wp-content/uploads/Gametocyte-specific-and-all-blood-stage-transmission-blocking-chemotypes-discovered-from-high-throughput-screening-on-Plasmodium-falciparum-gametocytes_Communic.-Bio_June-.png https://www.irbm.com/news/irbm-signs-crispr-cas9-license-agreement/ 2025-08-29T15:26:45+00:00 https://www.irbm.com/wp-content/uploads/ERS-GENOMICS-IRBM-2024_WEBSITE.svg https://www.irbm.com/news/pioneering-the-future-of-cancer-treatment-highlights-from-the-third-annual-nci-chemical-biology-consortium-symposium/ 2025-08-29T15:26:51+00:00 https://www.irbm.com/wp-content/uploads/IRBM-NEWS_2024-CBC-catch-the-wave-1-scaled.jpg https://www.irbm.com/wp-content/uploads/Catch-the-Wave-2024_IRBM-NEWS-scaled.jpg https://www.irbm.com/scientific-publications/publications-2020/cyclic-phosphopantothenic-acid-prodrugs-for-treatment-of-pantothenate-kinase-associated-neurodegeneration/ 2025-08-29T15:27:04+00:00 https://www.irbm.com/scientific-publications/publications-2015/niraparib-a-polyadp-ribose-polymerase-parp-inhibitor-for-the-treatment-of-tumors-with-defective-homologous-recombination/ 2025-08-29T15:28:30+00:00 https://www.irbm.com/scientific-publications/publications-2017/phosphorylation-of-huntingtin-at-residue-t3-is-decreased-in-huntingtons-disease-and-modulates-mutant-huntingtin-protein-conformation/ 2025-08-29T15:28:41+00:00 https://www.irbm.com/scientific-publications/publications-2018/discovery-of-2-1h-imidazo-2-ylpiperazines-as-a-new-class-of-potent-and-non-cytotoxic-inhibitors-of-trypanosoma-brucei-growth-in-vitro/ 2025-08-29T15:28:49+00:00 https://www.irbm.com/scientific-publications/publications-2019/phospho-s129-alpha-synuclein-is-present-in-human-plasma-but-not-in-cerebrospinal-fluid-as-determined-by-an-ultrasensitive-immunoassay/ 2025-08-29T15:28:57+00:00 https://www.irbm.com/scientific-publications/publications-2016/conformational-modulation-mediated-by-polyglutamine-expansion-in-cag-repeat-expansion-disease-associated-proteins/ 2025-08-29T15:29:12+00:00 https://www.irbm.com/news/discovery-and-characterization-of-novel-peptide-inhibitors-of-the-nrf2-mafg-dna-ternary-complex-for-the-treatment-of-cancer/ 2025-08-29T15:29:23+00:00 https://www.irbm.com/wp-content/uploads/irbm-novel-peptide-inhibitors-NRF2-MAFG-DNA_1280x730.jpg https://www.irbm.com/scientific-publications/publications-2022/discovery-of-mk-1462-glp-1-and-glucagon-receptor-dual-agonist-for-the-treatment-of-obesity-and-diabetes/ 2025-08-29T15:29:34+00:00 https://www.irbm.com/wp-content/uploads/Discovery-of-MK-1462-GLP-1-and-Glucagon-Receptor-Dual-Agonist-for-the-Treatment-of-Obesity-and-Diabetes_ACS-Med-Chem-Letters_Aug-2022.png https://www.irbm.com/scientific-publications/publications-2020/ultrasensitive-quantitative-measurement-of-huntingtin-phosphorylation-at-residue-s13/ 2025-08-29T15:29:43+00:00 https://www.irbm.com/scientific-publications/publications-2016/mk-4101-a-potent-inhibitor-of-the-hedgehog-pathway-is-highly-active-against-medulloblastoma-and-basal-cell-carcinoma/ 2025-08-29T15:29:55+00:00 https://www.irbm.com/news/advancing-discovery-through-inclusion-the-women-of-irbm/ 2025-09-01T13:19:38+00:00 https://www.irbm.com/wp-content/uploads/Advancing-Discovery-Through-Inclusion-The-Women-of-IRBM-scaled.jpg https://www.irbm.com/news/irbm-featured-in-national-made-in-italy-showcase-of-italian-ingenuity-and-industrial-excellence/ 2025-09-01T13:22:07+00:00 https://www.irbm.com/wp-content/uploads/Made-in-Italy-News-Banner-1-scaled.jpg https://www.irbm.com/news/irbm-joins-the-2024-g7-ministerial-meeting-on-development-to-advance-global-health-innovation/ 2025-09-01T13:36:20+00:00 https://www.irbm.com/wp-content/uploads/G7_news_cover_02-scaled.jpg https://www.irbm.com/events/efmc-asmc-2025/ 2025-09-04T14:36:23+00:00 https://www.irbm.com/wp-content/uploads/EFMC-ASMC-2025.png https://www.irbm.com/news/irbm-expands-functional-genomics-platform-to-strengthen-early-drug-discovery/ 2025-09-04T15:12:32+00:00 https://www.irbm.com/wp-content/uploads/PRESS-GENOMICS-IRBM-2025_blue-scaled.jpg https://www.irbm.com/events/bps2025/ 2025-09-19T09:50:22+00:00 https://www.irbm.com/wp-content/uploads/BPS-2025.png https://www.irbm.com/events/ddip-2025/ 2025-09-29T10:18:45+00:00 https://www.irbm.com/wp-content/uploads/DDIP-2025-Event.png https://www.irbm.com/events/european-biotech-week-2025/ 2025-10-01T10:29:45+00:00 https://www.irbm.com/wp-content/uploads/BiotechWeek-Banner-2025_2.0.png https://www.irbm.com/events/european-society-for-spatial-biology-essb-2025/ 2025-10-17T08:50:56+00:00 https://www.irbm.com/wp-content/uploads/ESSB-2025.png https://www.irbm.com/events/drug-discovery-2025-elrig/ 2025-10-22T08:59:41+00:00 https://www.irbm.com/wp-content/uploads/DRUG-DISCOVERY-2025.png https://www.irbm.com/events/aacr-nci-eortc-202/ 2025-10-27T08:25:18+00:00 https://www.irbm.com/wp-content/uploads/AACR-NCI-EORTC-2025-1.png https://www.irbm.com/scientific-publications/publications-2025/modulation-of-huntingtin-s421-phosphorylation-in-a-huntingtons-disease-mouse-model-and-its-detection-in-nonhuman-primate-cerebrospinal-fluid/ 2025-11-03T15:31:07+00:00 https://www.irbm.com/wp-content/uploads/Cover-image-bioRxiv-Modulation-of-huntingtin-S421-phosphorylation-in-a-Huntingtons-disease-mouse-model-and-its-detection-in-nonhuman-primate-cerebrospinal-fluid-scaled.jpg https://www.irbm.com/events/bio-europe-2025/ 2025-11-05T09:38:00+00:00 https://www.irbm.com/wp-content/uploads/BIO-EUROPE-2025.png https://www.irbm.com/scientific-publications/publications-2025/novel-azabicyclic-series-of-potent-shp2-allosteric-inhibitors/ 2025-11-11T16:42:23+00:00 https://www.irbm.com/wp-content/uploads/Bioorganic-Medicinal-Chemistry-Letters-e1756391747114.jpg https://www.irbm.com/events/drug-discovery-chemistry-europe-2025/ 2025-11-13T10:14:59+00:00 https://www.irbm.com/wp-content/uploads/Drug-Discovery-Chemistry-2025.png https://www.irbm.com/events/tides-europe-2025/ 2025-11-17T11:58:08+00:00 https://www.irbm.com/wp-content/uploads/TIDES-2025-1.png https://www.irbm.com/events/neuroscience-2025/ 2025-11-25T10:13:21+00:00 https://www.irbm.com/wp-content/uploads/SfN-2025.png https://www.irbm.com/events/18th-ebf-open-symposium-2025/ 2025-11-25T10:18:07+00:00 https://www.irbm.com/wp-content/uploads/EBF-2025-2.png https://www.irbm.com/events/biofit-2025-strasbourg/ 2025-12-03T16:17:05+00:00 https://www.irbm.com/wp-content/uploads/Biofit-2025-1.png https://www.irbm.com/events/slas-2026/ 2026-02-11T17:40:00+00:00 https://www.irbm.com/wp-content/uploads/SLAS-2026.png https://www.irbm.com/news/irbm-the-first-integrated-drug-discovery-cro-in-italy-to-install-brukers-rapiflex-maldi-tissuetyper/ 2026-02-12T15:52:01+00:00 https://www.irbm.com/wp-content/uploads/IRBM-News-Maldi-TOF-TOF-scaled.jpg https://www.irbm.com/news/irbm-reports-breakthrough-in-zika-virus-drug-discovery/ 2026-02-12T15:59:42+00:00 https://www.irbm.com/wp-content/uploads/Zika-press-release-banner_03-scaled.jpg https://www.irbm.com/scientific-publications/publications-2026/an-allosteric-inhibitor-of-the-zika-virus-ns2b-ns3-protease-with-oral-efficacy-in-mouse-models/ 2026-02-13T14:53:48+00:00 https://www.irbm.com/wp-content/uploads/Nature-Communications-Cover-2.0-scaled.jpg https://www.irbm.com/events/it-gpcr-network-2026-bari/ 2026-02-20T11:49:55+00:00 https://www.irbm.com/wp-content/uploads/Italian-GPCR-Network-2026.png https://www.irbm.com/events/chdi2026/ 2026-02-26T08:51:44+00:00 https://www.irbm.com/wp-content/uploads/CHDI-2026.png https://www.irbm.com/events/car-tcr-summit-europe-2026-london/ 2026-02-26T08:52:33+00:00 https://www.irbm.com/wp-content/uploads/CAR-TCR-Summit-Europe-1.png https://www.irbm.com/events/tides-asia-2026-tokyo/ 2026-02-26T08:53:48+00:00 https://www.irbm.com/wp-content/uploads/TIDES-ASIA-2026.png https://www.irbm.com/careers-list/head-of-drug-metabolism-and-pharmacokinetics-dmpk/ 2026-03-12T14:34:28+00:00 https://www.irbm.com/events/high-content-crispr-screening-conference/ 2026-03-20T07:44:53+00:00 https://www.irbm.com/wp-content/uploads/HC-CRISPR-2026-1.png https://www.irbm.com/events/dutch-symposium-on-organic-chemistry-2026/ 2026-03-20T07:45:46+00:00 https://www.irbm.com/wp-content/uploads/DSOC-2026.png https://www.irbm.com/events/bio-europe-spring-2026/ 2026-03-25T08:58:08+00:00 https://www.irbm.com/wp-content/uploads/BIO-EU-SPRING-2026.png https://www.irbm.com/scientific-contributions/irbms-drug-discovery-research-is-featured-on-the-cover-of-this-issues-acs-publications-medicinal-chemistry-letters/ 2026-04-16T07:49:57+00:00 https://www.irbm.com/wp-content/uploads/irbm-Discovery-of-a-Novel-Series-of-Imidazopyrazine-Derivatives-1.webp https://www.irbm.com/events/ddc-drug-discovery-chemistry-2026/ 2026-04-16T13:10:03+00:00 https://www.irbm.com/wp-content/uploads/Drug-Discovery-Chemistry-2026.png https://www.irbm.com/events/aacr-2026/ 2026-04-24T15:05:47+00:00 https://www.irbm.com/wp-content/uploads/AACR-2026.png https://www.irbm.com/factsheets/no-shortcuts-no-fluff-just-great-science-that-moves-discoveries-forward/ 2026-05-06T09:51:18+00:00 https://www.irbm.com/wp-content/uploads/facsheet-cover.png https://www.irbm.com/events/icar-2026/ 2026-05-06T11:49:21+00:00 https://www.irbm.com/wp-content/uploads/ICAR-2026.png https://www.irbm.com/news/irbm-earns-aaalac-international-accreditation/ 2026-05-07T10:24:42+00:00 https://www.irbm.com/wp-content/uploads/IRBM-AAALAC-Acreditation_News-Cover-scaled.jpg https://www.irbm.com/scientific-publications/publications-2026/plasma-metabolomic-profiling-identifies-a-metabolic-signature-for-non-muscle-invasive-bladder-cancer-independent-of-hematuria/ 2026-05-13T13:23:36+00:00 https://www.irbm.com/wp-content/uploads/Biology-Direct_Cover_IRBM-Article.webp https://www.irbm.com/events/tides-usa-2026/ 2026-05-18T07:54:33+00:00 https://www.irbm.com/wp-content/uploads/TIDES-2026.png https://www.irbm.com/scientific-publications/publications-2026/discovery-and-optimization-of-irbm-z-2-an-allosteric-zika-virus-ns2b-ns3-protease-inhibitor-exhibiting-in-vivo-efficacy/ 2026-05-30T20:27:26+00:00 https://www.irbm.com/wp-content/uploads/Journal-Of-Medicinal-Chemistry_COVER_ACS-Publications_2.0.jpg https://www.irbm.com/events/nmcs-acs-2026/ 2026-06-03T08:57:22+00:00 https://www.irbm.com/wp-content/uploads/NMCS-ACS-2026-2.png https://www.irbm.com/events/discoverydevelopment-europe-berlin-2026/ 2026-06-16T14:31:57+00:00 https://www.irbm.com/wp-content/uploads/Discovery-Development-Europe-2026.png https://www.irbm.com/events/bio-international-2026/ 2026-06-25T13:55:36+00:00 https://www.irbm.com/wp-content/uploads/BIO-International-Convention-2026.png https://www.irbm.com/news/irbm-expands-its-purification-and-automation-suite/ 2026-07-01T08:07:34+00:00 https://www.irbm.com/wp-content/uploads/IRBM-News_AutomationLab-scaled.jpg https://www.irbm.com/careers-list/principal-research-scientist/ 2026-07-13T09:57:32+00:00 https://www.irbm.com/discovery-bites/most-drug-discovery-programs-underestimate-the-bioanalytical-challenge-of-metal-labeled-compounds-heres-how-to-close-the-gap/ 2026-07-17T09:25:44+00:00 https://www.irbm.com/wp-content/uploads/3.-ICP-MS-w_logo-scaled.jpg https://www.irbm.com/wp-content/uploads/Immagine1-1.png https://www.irbm.com/news/optimizing-covalent-hit-discovery-a-practical-approach-to-fragment-screening/ 2026-07-17T09:25:47+00:00 https://www.irbm.com/wp-content/uploads/5.-PROTAC-w_logo-scaled.jpg https://www.irbm.com/discovery-bites/our-peptide-chemistry-facility/ 2026-07-17T09:26:05+00:00 https://www.irbm.com/wp-content/uploads/4.-Peptides-video-w_logo-scaled.jpg https://www.irbm.com/discovery-bites/compound-collection-management-dynamic-fully-automated-platform-and-operative-workflow-for-high-throughput-screening/ 2026-07-17T09:26:07+00:00 https://www.irbm.com/wp-content/uploads/6.-EFMC-video-w_logo-scaled.jpg https://www.irbm.com/discovery-bites/the-sound-of-structural-biology/ 2026-07-17T13:21:03+00:00 https://www.irbm.com/wp-content/uploads/icon-structural-biology.png https://www.irbm.com/careers-list/business-development-director-senior-director-us-territories-dach-region/ 2026-07-27T09:47:04+00:00 https://www.irbm.com/discovery-bites/peptide-drug-discovery-in-2026-how-macrocycles-display-technologies-and-integrated-development-are-rewriting-the-rules/ 2026-08-03T06:56:56+00:00 https://www.irbm.com/wp-content/uploads/2.-Peptides-TIDES-w_logo-scaled.jpg https://www.irbm.com/scientific-publications/publications-2026/discovery-and-preclinical-characterization-of-i-0436650-a-selective-shp2-allosteric-inhibitor-for-ras-driven-cancers/ 2026-08-06T08:47:50+00:00 https://www.irbm.com/wp-content/uploads/Journal-Of-Medicinal-Chemistry_COVER_ACS-Publications_2.0.jpg https://www.irbm.com/careers-list/accounting-finance-specialist-3/ 2026-08-07T12:17:03+00:00 https://www.irbm.com/careers-list/specialista-manutenzione-elettrica/ 2026-08-12T12:28:41+00:00 https://www.irbm.com/events/efmc-2026/ 2026-08-14T08:53:42+00:00 https://www.irbm.com/wp-content/uploads/EFMC-2026-1.png